Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

A 2% green tea extract shows promise in the treatment of papulopustular rosacea

Feb. 22, 2005

Spotlight on N-palmitoylethanolamide: multiple potential therapeutic effects

Feb. 22, 2005

IDEA-070 studied in phase II trial for inflammatory skin diseases

Feb. 21, 2005

Favorable efficacy, safety, pharmacokinetic profiles reported on anti-IL-12p40 in psoriasis patients

Feb. 21, 2005

Efficacy of DA-9102 as a treatment for atopic dermatitis shown in NC/Nga mice

Feb. 21, 2005

Antiirritative efficacy of licochalcone shown in volunteers with induced erythema

Feb. 21, 2005

Efficacy of the natural triterpene product BSP-103 demonstrated in patients with psoriasis

Feb. 21, 2005

Excessive scarring prevented by 4-hydroxy tamoxifen (4-OHT)

Feb. 18, 2005

Vanos receives FDA approval

Feb. 16, 2005

Further monitoring required for Elidel, Protopic postmarketing adverse events

Feb. 16, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...